Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance

Go back to Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance

Dynavax (DVAX) Tops Q4 EPS by 4c

February 23, 2023 4:14 PM EST

Dynavax (NASDAQ: DVAX) reported Q4 EPS of $0.45, $0.04 better than the analyst estimate of $0.41. Revenue for the quarter came in at $184.5 million versus the consensus estimate of $179.6 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

... More